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Abstract

It has recently been reported that whole skeletal development is normal or even increased in
spontaneously hypertensive (SH) rats compared to normotensive controls (DeMoss and Wright,
1998). Using the 3H-tetracycline model, whole body skeletal bone resorption was compared

'
between male and female hypertensive SH and normotensive Wistar Kyoto (WKy) and SpragueDawley (SD) rats. An indication of significantly elevated resorption, both in terms of iate of
resorption and extent of metabolically reactive bone, was detected in SH rats at 8 weeks of age.
In mature animals (24 week old) the rate ofresorption (52% to 135%) and extent of
metabolically reactive bone (39% to 88%) were significantly elevated in females

comp~red to
'

males in each of the three rat strains studied. In within sex comparisons of 24 week

014 animals,

the bone resorptive activity was similar in normotensive WKy and SD groups. By comparison,
the resorptive activity of both male and female SH rats was significantly increased com~ared to
normotensive controls. This was particularly true in female SH rats which showed 40% and 78%
elevation in rate of resorption and extent of metabolically reactive bone, respectively, in
comparison with normotensive female controls. In light of normal or enhanced skeletal
development in SH rats, the present results indicate a dramatically higher level of bone turnover
in hypertensives that is detectable as early as eight weeks of age.

Index Terms: Skeleton, resorption, bone, SHR, hypertension

3

Introduction

There is substantial indirect evidence suggesting a possible link between hypertension and
osteoporotic disease. High levels of PTH are seen in osteoporotic (9) and hypertensive patients
(20). Patients with osteoporosis often exist in a hyperparathyroid state (4, 24) and it is reported
that a large portion of individuals with osteoporosis have blood pressure greater than normal (10,
15). Patients with essential hypertension as well as animal models of hypertension (SHR) show
decreased JJlasma ionic calcium, increased PTH, and increased urinary excretion of calcium (16,
18, 20, 26). Blood pressure in both humans and SHR is reduced by parathyroidectomy; whereas,

''

increased dietary calcium has been shown to both delay the onset and reduce the severity of
'

hypertension (1, 3, 17). Hence, it may be reasonable to speculate that bone metabolism is altered
in hypertension where PTH is elevated and calcium metabolism is abnormal.

Experimental evaluation of bone metabolism in hypertension is limite!i. Earlier studies indicated
bone calcium content (5, 19) was not different between SHR and normotensive animals. Other
studies; however, found evidence of decreased cortical bone mass and increased numbers of
osteoclasts in the hypertensive rat ( 12, 22). More recently, evidence for decreased trabecular
bone volume and increased bone turnover has been reported for SHR (2, 25). Hence;results
from the study of individual bones are generally consistent with increased bone turnover leading
to bone loss in older hypertensive animals. It has been demonstrated in whole animal studies;
however, that development of skeletal mass in SH rats is normal or enhanced compared to
normotensive controls (7). In the present study, the 3H-tetracycline model was utilized to

•..
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compare skeletal resorptive activity between SH and two normotensive rat strains. Thtb results
'

indicate a marked increase of skeletal bone resorption in hypertension that is apparent in both
young growing animals as well as in mature rats.

Materials and Methods

The animals utilized were Sprague-Dawley (SD/HlaBR, Hilltop Lab Animals, Scottsdale, PA),
Wistar Kyoto (WKy/NCr!BR, Charles River, Wilmington, MA), and Aoki-Okamoto, '
spontaneously hypertensive rats (SHR/NCr!BR, Charles River, Wilmington, MA). Animals
were maintained in colony rooms at 23 ± 2 °C on a 12h light/dark photoperiod and were allowed
free access to Purina Rat Chow and tap water. The systolic blood pressure of selected groups of
rats from each strain was measured with the animal conscious using a programmed
electrosphygmomanometer with pneumatic pulse transducer and tail-cuff.

iH-Tetracycline Method for Measnrement of Whole Skeleton Bone Resorption. Whole

skeleton bone resorption was measured as previously described ( 6). Thirteen days prior to the
start of urine collection a total of 12 male and 12 female rats of each of the SH, WKy and SD
'

strains at either 6 weeks or 22 weeks of age underwent a series of subcutaneous injections of 3Htetracycline (NET-141 Tetracycline, [7-3HCN]; New England Nuclear, Boston MA) dissolved in
0.05 M HCl containing ascorbic acid as a reducing agent. At the end of the isotope labrling
period, 8 week old rats had received a total of 25 µCi/rat in five injections while 24 we~k old rats
received a total of35 µCi/rat 3H-tetracycline in five injections on days l, 4, 7, 10, and ~3.

'
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Following the final injection, each rat was transferred to a standard metabolic chamber and its
1

food consumption and body weight were monitored daily. The first 24-h urine was discarded
and the urine was collected thereafter at 24-h intervals for a period of 35 days. Urine vplume
was recorded daily and a 0.5 ml aliquot from each sample was combined with 10 ml of
Scintiverse E (Fisher Scientific; Pittsburgh, PA) to determine 3H-tetracycline content by liquid
scintillation spectrometry. The relationship between body mass and dry skeletal mass previously
determined for each of the rat strains (7) was utilized to normalize the urinary 3-H-tetra<;:ycline
loss curve data for the dry skeletal mass of each rat at the end of isotope injection. Individual
curves were then analyzed by Table Curve 2D Automated Curve Fitting Software (Jandel
Scientific, San Rafael, CA). Based on the equation obtained, the curves were further arialyzed to
I

obtain the following parameter for the slow compartment of label loss which is thought 1to
represent cell-mediated bone resorption; (!) y-intercept, the rate oflabel loss from the actively
I

resorbing bone compartment immediately following termination of label loading. This ,
parameter provides a measure of the rate of resorption uncomplicated by previous depl~tion of
label from resorbing bone; (2) area under the curve or pool size, this parameter serves as a
measure of the extent of metabolically reactive bone; (3) 't, an estimate ofx-intercept which
represents the time constant for 63% depletion of the labeled pool (5

't,

the depletion ti~e, equals

the number of days required for> 98% pool label turnover). This parameter reflects the
proportionality of the interaction ofrate of resorption and pool size. For example, a de~rease in
I

depletion time would indicate greater rate of resorption relative to pool size.
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Statistics

'1

The regression parameters were analyzed for significant difference via Three Factor ANOVA
I

(Super ANOVA:Abacus Concepts, Berkeley, CA). Differences were considered signiflcant if
P < 0.05. Data are presented as mean± SEM throughout the text.

Results

Figure 1 shows the pattern of blood pressure development of SH and normotensive WK.y and SD
rats in the interval from 8 to 24 weeks of age. Both male and female SH rats showed el,evation of
blood pressure to hypertensive levels by 8 weeks of age. Thereafter, blood pressure coltinued to

i
I

increase with severe hypertension realized in 24 week old animals. The blood pressure!
development in WK.y, the parent strain of SHR (23), and SD rats also increased with maturity but
were well below that ofSHR. Each of the rat strains investigated showed a dichotomy ?fblood
I

pressure development between sexes, with the values obtained in females significantly lower
than those of males.

Skeletal Resorption Kinetic Parameters. Significant differences were observed among rapidly
I

I

growing 8 week old animals of the three rat strains in both the rate ofresorption (Table [)and
pool size (Table 2). WK.y values tended to be higher than SD values; however, the rate

~f

resorption and pool size in both male and female SHR was significantly increased comp:ared to

!
either the WK.y or SD groups. The increase of both of these parameters in SHR relative!to

,

/
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controls was such that pool depletion time (Table 3) was reduced in both male (10% to 24%) and
I

females (19%). Although rate ofresorption and pool size tended to be reduced in females
I

!

compared to males there was no consistent evidence of sexual dichotomy in resorption:
parameters at 8 weeks of age.

There was a dramatic decrease in male values for rate ofresorption (60% to 70%) and pool size
(75% to 80%) between 8 and 24 weeks of age. Female values also decreased for rate of
resorption (15% to 35%) and pool size (45% to 60%) but to a lesser extent than seen in males. In
24 week old animals there was a clear sexual dichotomy with elevated female rate of resorption
and pool size recorded for each of the three rat strains. Within sex comparisons indicated no
differences in rate of resorption (Table 1), pool size (Table 2) or depletion time (Table 3)
between normotensive 24 week old WKy and SD rats. Male SHR showed significantly
increased rate of resorption compared to both WKy and SD rats at 24 weeks. Pool size of24
'

week old male SHR was also increased relative to SD rats; whereas, no significant difference in
depletion time was evident among males of the three rat strains. By comparison 24 week old
female SHR showed consistently increased resorption values compared to both the normotensive
WKy and SD controls. In addition, the depletion time of female SHR was significantly reduced,
reflecting a disproportionate elevation in rate of resorption.
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Discussion

The spontaneously hypertensive rat (SHR) is a widely studied model of essential hypel)tension
that exhibits similar properties of abnormal
calcium metabolism to those seen in humfili'
.
hypertensives. Urinary calcium loss is increased in SHR with hypercalcuira reported by 17
weeks of age in males with associated decreased serum ionized calcium and elevated PTH levels
(14). Although still an area of controversy, there is an extensive literature suggesting that
gastrointestinal handling of calcium is significantly altered in SHR (reviewed in 11). Taken
together, the literature clearly indicates significant disturbance of various factors regulating
calcium metabolism in hypertension that could affect bone mineral metabolism.

Depletion time may serve as an indicator of the proportionality between the rate or inten~ity of
cell-mediated resorptive activity and the pool size or extent of metabolically reactive bo11e. For
example, both the rate of resorption and pool size decreased dramatically between 8 and ?4
weeks of age indicating a significant overall decrease in resorptive function in mature animals.
However, this was accompanied by a corresponding decrease in depletion times indicating that
the shrinkage in pool size (males, 77%; females, 56%) was disproportionately high relative to the
'

decrease in rate or intensity ofresorptive function (males, 63%; females, 26%). Hence, the
strategy for reduced resorption in mature animals appears to center on a reduction in extent of
metabolically reactive bone although the rate or intensity of resorption may vary within this
smaller compartment. At 24 weeks of age, female rats showed both less reduction in pool, size
'

and exaggerated disproportionality ofreduction in rate ofresorption compared to males. This
I

9
pattern was particularly pronounced in female SHR.

Various studies to evaluate individual bone densities (13, 21) ash weights (12) and
histomorphormetric characteristics (25, 27) are generally consistent with increased bone
catabolism and reduced bone mineralization in mature SHR. In recognition of the potential
danger in extrapolating individual bone data to the intact skeleton, a recent study examined
'

whole skeletal dry weight and calcium content of SHR in comparison to WKy and SD rats (7). It
was found that skeletal development. expressed as dry skeletal mass percent of body weight, was
significantly increased in the females of each strain at both 8 weeks (- 25%) and 24 weeks (35%) of age. Within sex comparisons further indicated that skeletal development of SHR was
significantly increased compared to WKy and SD controls in 24 week old males and in females
at both 8 weeks and 24 weeks of ages. Moreover, they showed that the calcium content per gram
of bone was identical among the three rat strains. Hence, whole body assessment indica,ted
robust skeletal development and normal calcium content in skeletons of females compared to
males and in hypertensive versus normotensive rats. Together with the present findings of
elevated whole skeletal bone resorption, these results indicate that turnover, both bone formation
and resorption, are markedly increased in hypertensive rats.

The results indicate strong between-sex differences in mature animals with females exhibiting
'

I

both increased rate of resorption (Table 1) and pool size (Table 2) compared to males. The
I
reason for increased resorptive activity in females is uncertain. The turnover of bone in rats at 24
'

weeks of age would be expected to involve significant remodeling and modeling activiti\!s

•
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associated with repair and bone sculpting (8). In addition, skeletal bone turnover represents a
I

major mechanism in extracellular fluid calcium homeostasis. Because it seems unlikely that
remodeling or modeling would be elevated in unbred females compared to males, a likely

'

explanation is that the increased resorptive activity is, in some fashion, linked to calcium
homeostasis in the female. This, in tum, would appear consistent with the exacerbation of the
phenomenon in SHR which exhibit evidence of disturbed calcium homeostasis.

In summary, a comparison among SH. WK.y and SD rat strains indicated, as expected, 1that whole
body skeletal bone resorption was dramatically reduced between rapidly growing 8 week old and
mature 24 week old animals. It was further found that in mature animals, whole skeletal
resorptive activity was significantly elevated in females of each strain, compared to males. An
increase in resorptive activity in SH rats compared to normotensive animals was detect.ed as early
as 8 weeks of age. Increased resorption was clearly present in hypertensives at 24 wee~s of age
and was particularly severe in female SHR. The cause of increased bone turnover in females or
hypertensives is not certain but may be linked to the demands of whole body calcium
homeostasis in these animals. In light of previous work (7), the results are suggestive that the
stress placed on the skeleton by calcium homeostasis could be a major factor to increase skeletal
mass in the mature animal in circumstances where adequate dietary calcium is available. On the
other hand, the high basal level of bone turnover in female and hypertensive animals would be
expected to increase their susceptibility to bone loss in circumstances of calcium deficiency or
osteoporotic disease.

'
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Table 1.

The rate of 3H-tetracycline label loss (y-intercept) of 8 and 24 week old. male and
female SH, WK.y and SD rats.

8Week
Male

Female

Female/Male

SD

14.7 ±I.I

14.9 ± 1.8

l.Ot'

WK.y

27.0± I.I*

18.9 ± 0.8"

0.70

SHR

34.3 ± 1.l*t

32.7 ± 1.4*t

0.95

24 Week
SD

5.8 ± 0.6

12.9 ± 0.6"

2.22,

WK.y

8.2 ± 0.6

12.5 ± 0.8"

1.56-

SHR

9.6± 0.4*'

22.6 ± 2.4"*t

2.35

Data are presented as DPM/gm DSM x10-3, values indicate the average ±SEM of 6 animals
* indicates significant difference from SD.,.value
'

indicates significant difference from WK.y value

" indicates difference between sexes of the same strain

•
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Table 2.

3

H-tetracycline label pool size of 8 and 24 week old male and female SHR, WKy

and SD rats.

8Week
Female

Female/Male

SD

532.0 ± 22.2

494.4± 32.8

0.92

WKy

832.3 ± 19.5*

647.1±22.5"*

0.78

SHR

958.2.± l 7.4*t

901.2 ± 44.0*'

0.94
'

I
I

'!

24 Week

SD

138.8 ± 10.8

260.I ± 5.7"

1.87

WKy

178.0 ± 11.0

248.0 ± 4.5"

1.39'

SHR

205.2 ± I 0.3*

357.0 ± 20.2 "*'

1.74

I

Data are presented as DPM/gm DSM x10·3 , values indicate the average ±SEM of 6 apimals
• significant difference between sexes of the same strain
* significant difference from SD value
t significant difference from WKy value

•
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Table 3..

Depletion time (days) for the 3H-tetracycline label from the skeleton of 8 and 24

I

week old male and female SHR, WKy, and SD rats.

8Week
Female

SD

73.7 ± 3.7

68.5 ± 3.9

WKy

62.1 ± 1.8*

68.6 ± 1.9

SHR

56.0 ± 2.0*

55.3 ± 1.5*•

24 Week
SD

48.9± 1.8

40.7 ± 2.1"

WKy

43.7 ± 2.3

40.2 ± 2.0

SHR

43.2± 2.7

32.4 ± [. 7"*+

" indicates significant differences between sexes of the same strain

*

significant difference from SD value.

+ significant difference from WKy value.
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Figure Legends

Figure 1

Systolic blood pressure development in male and female spontaneously
hypertensive (SH), Wistar Kyoto (WKy) and Sprague-Dawley (SD) rats
between 8 weeks and 24 weeks of age. Values represent the average of six

'
animals.

